FindTrial
Sign In

Value of umbilical cord blood white blood cell, procalcitonin, C-reactive protein, erythrocyte distribution width and platelet ratio in evaluating the condition and prognosis of critically ill neonates

Value of umbilical cord blood white blood cell, procalcitonin, C-reactive protein, erythrocyte distribution width and platelet ratio in evaluating the condition and prognosis of critically ill neonates

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043217
Enrollment
Unknown
Registered
2021-02-08
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

critical neonates

Interventions

Gold Standard:The neonatal emergency physiological score
Index test:The&#32
changes&#32
of&#32
umbilical&#32
cord&#32
blood&#32
leukocytes,&#32
procalcitonin,&#32
C-reactive&#32
protein,&#32
red&#32
cell&#32
distribution&#32
width&#32
and&#32
platelet&#32
ratio&#32
(RPR).

Sponsors

Cangzhou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Neonates admitted to the Neonatal Intensive Care Unit; (2) and admitted within 1 hour after birth; (3) Children with umbilical cord blood samples collected after birth.

Exclusion criteria

Exclusion criteria: (1) Duration of hospital stay < 72h; (2) Cases whose family members refused to be enrolled; (3) Cases with incomplete clinical data. (4) People suffering from genetic metabolic diseases or developmental deformity.

Design outcomes

Primary

MeasureTime frame
SNAPPE II;SEN, SPE, ACC, AUC of ROC, PPV, NPV;—

Countries

China

Contacts

Public ContactBin-Fang Guo

Cangzhou Central Hospital

gbf1112@126.com+86 15350775055

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026